These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38298904)

  • 1. Summary of the National Advisory Committee on Immunization (NACI) Statement-Recommendations on Fractional Influenza Vaccine Dosing in the Event of a Shortage: Pandemic preparedness.
    Sinilaite A; Doyon-Plourde P; Young K; Harrison R
    Can Commun Dis Rep; 2023 Apr; 49(4):90-98. PubMed ID: 38298904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Summary of the National Advisory Committee on Immunization (NACI) Statement on Seasonal Influenza Vaccine for 2016-2017.
    Gemmill I; Zhao L; Cochrane L;
    Can Commun Dis Rep; 2016 Sep; 42(9):188-192. PubMed ID: 29770030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summary of the National Advisory Committee on Immunization (NACI) Statement on Seasonal Influenza Vaccine for 2015-2016.
    Gemmill I;
    Can Commun Dis Rep; 2015 Oct; 41(10):227-232. PubMed ID: 29769917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2022-2023.
    Sinilaite A; Papenburg J
    Can Commun Dis Rep; 2022 Sep; 48(9):373-382. PubMed ID: 38116046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Summary of the NACI Statement on Seasonal Influenza Vaccine for 2017-2018.
    Vaudry W; Stirling R;
    Can Commun Dis Rep; 2017 May; 43(5):96-103. PubMed ID: 29770072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Summary of the NACI Seasonal Influenza Vaccine Statement for 2018-2019.
    Vaudry W; Zhao L; Stirling R
    Can Commun Dis Rep; 2018 Jun; 44(6):123-128. PubMed ID: 31015804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Summary of the NACI Supplemental Statement on Mammalian Cell Culture-Based Influenza Vaccines.
    Sinilaite A; Gemmill I; Harrison R
    Can Commun Dis Rep; 2020 Oct; 46(10):324-332. PubMed ID: 33316000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Summary of the NACI Seasonal Influenza Vaccine Statement for 2019-2020.
    Zhao L; Young K; Gemmill I
    Can Commun Dis Rep; 2019 Jun; 45(6):149-155. PubMed ID: 31285706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2021-2022.
    Can Commun Dis Rep; 2021 Sep; 47(9):372-380. PubMed ID: 34650334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summary of the National Advisory Committee on Immunization (NACI) Statement-Recommendation on Repeated Seasonal Influenza Vaccination.
    Sinilaite A; Young K; Papenburg J
    Can Commun Dis Rep; 2023 Apr; 49(4):99-102. PubMed ID: 38298903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2023-2024.
    Sinilaite A; Siu W; Papenburg J
    Can Commun Dis Rep; 2023 Oct; 49(10):406-412. PubMed ID: 38476927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summary of the National Advisory Committee on Immunization (NACI) Updated Guidance on Influenza Vaccination During Pregnancy.
    Siu W; Sinilaite A; Papenburg J
    Can Commun Dis Rep; 2024 Apr; 50(3-4):86-92. PubMed ID: 38716409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Summary of the NACI Seasonal Influenza Vaccine Statement for 2020-2021.
    Young K; Gemmill I; Harrison R
    Can Commun Dis Rep; 2020 May; 46(5):132-137. PubMed ID: 32558810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summary of the National Advisory Committee on Immunization (NACI) Supplemental Statement on Recombinant Influenza Vaccines.
    Gil A; Sinilaite A; Papenburg J
    Can Commun Dis Rep; 2022 Sep; 48(9):383-391. PubMed ID: 38116047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Summary of the National Advisory Committee on Immunization (NACI) Rapid Response: Updated interim guidance on Imvamune in the context of ongoing monkeypox outbreaks.
    Forbes N; Baclic O; Harrison R; Brousseau N
    Can Commun Dis Rep; 2022 Nov; 48(11-12):580-586. PubMed ID: 38192609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Summary of the National Advisory Committee on Immunization's updated recommendations on human papillomavirus (HPV) vaccines: Nine-valent human papillomavirus (HPV) of minimum intervals between doses in the HPV immunization schedule.
    Tunis MC; Deeks SL;
    Can Commun Dis Rep; 2016 Jul; 42(7):149-151. PubMed ID: 29770021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Summary of the NACI Update on the recommended use of Human Papillomavirus (HPV) vaccine: Nine-valent HPV vaccine two-dose immunization schedule and the use of HPV vaccines in immunocompromised populations.
    Deeks SL; Tunis MC; Ismail S;
    Can Commun Dis Rep; 2017 Jun; 43(6):138-142. PubMed ID: 29770079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Summary of the NACI Update on Herpes Zoster Vaccines.
    Warrington R; Ismail S;
    Can Commun Dis Rep; 2018 Sep; 44(9):220-225. PubMed ID: 31015813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summary of the National Advisory Committee on Immunization (NACI) Statement Update on the Recommended Use of Hepatitis A Vaccine.
    Henry B; Baclic O;
    Can Commun Dis Rep; 2016 Sep; 42(9):193-194. PubMed ID: 29770031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summary of the NACI Update on the Recommended Use of Hepatitis B Vaccine.
    Henry B; Baclic O;
    Can Commun Dis Rep; 2017 May; 43(5):104-106. PubMed ID: 29770073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.